CLRB stock forecast
Our latest prediction for Cellectar Biosciences Inc's stock price was made on the March 4, 2021 when the stock price was at 1.74$.
In the short term (2weeks), CLRB's stock price should outperform the market by 2.97%. During that period the price should oscillate between -10.88% and +17.65%.
In the medium term (3months), CLRB's stock price should underperform the market by -0.34%. During that period the price should oscillate between -42.79% and +47.48%.
Get email alertsCreate a solid portfolio with CLRB
About Cellectar Biosciences Inc
cellectar biosciences is developing phospholipid drug conjugates (pdcs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. cellectar's pdc platform is based on the company's proprietary phospholipid ether analogs. these novel small-molecules have demonstrated highly selective uptake and retention in a broad range of cancers. cellectar's pdc pipeline includes product candidates for cancer therapy and cancer diagnostic imaging. the company's lead therapeutic pdc, clr 131, utilizes iodine-131, a cytotoxic radioisotope, as its payload. clr 131 has been designated as an orphan drug by the us fda and is currently being evaluated in a phase 1 clinical study in patients with relapsed or refractory multiple myeloma and a phase 2 clinical study to assess efficacy in a range of b-cell malignancies. the company is also developing proprietary pdcs for targeted delivery of chemotherapeutics and has several preclinical stage p
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.76$ per share.
The book value per share is 1.24$
Three months stock forecastMarch 4, 2021
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -15M | - | -15M | -0.76 | - | - | 20M | 1.24 | -14M | - | -14M |